Generics

Celgene has agreed to provide Cipla with a license to its patents required to manufacture and sell certain volume-limited amounts of generic lenalidomide in the United States beginning on a confidential date some time after March 2022.

Saphris had a market value of $239 million during the 12 months ended September 2020, according to industry data.

Camber's generic Sensipar tablets are available in 30-mg, 60-mg and 90-mg dosage strengths and come in 30-count bottles.

Teva's generic Entereg is available in a dosage strength of 12 mg.

Camber's generic Yasmin is available in 3 mg/0.03 mg-3 blister cards of 28 tablets.

Leucadia's generic Ofirmex provides a treatment for mild to moderate pain, management of moderate to severe pain with adjunctive opioid analgesics and reduction of fever.

Alembic’s metolazone tablets will be available in dosage strengths of 2.5 mg, 5 mg, and 10 mg.

Aurobindo's generic Acular will be available as a 0.5% strength ophthalmic solution.